Related references
Note: Only part of the references are listed.Factors Associated With Plasma IL-6 Levels During HIV Infection
Alvaro H. Borges et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Comparative impact of antiretroviral drugs on markers of inflammation and immune activation during the first two years of effective therapy for HIV-1 infection: an observational study
Suhaib Hattab et al.
BMC INFECTIOUS DISEASES (2014)
Interleukin-6, High Sensitivity C-Reactive Protein, and the Development of Type 2 Diabetes Among HIV-Positive Patients Taking Antiretroviral Therapy
Claude Betene A. Dooko et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2014)
Soluble Markers of Inflammation and Coagulation but Not T-Cell Activation Predict Non-AIDS-Defining Morbid Events During Suppressive Antiretroviral Treatment
Allan R. Tenorio et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Reduced sTWEAK and Increased sCD163 Levels in HIV-Infected Patients: Modulation by Antiretroviral Treatment, HIV Replication and HCV Co-Infection
Luis M. Beltran et al.
PLOS ONE (2014)
Severity of Cardiovascular Disease Outcomes Among Patients With HIV Is Related to Markers of Inflammation and Coagulation
Anna D. Nordell et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2014)
Microbial Translocation in HIV Infection Is Associated With Dyslipidemia, Insulin Resistance, and Risk of Myocardial Infarction
Karin K. Pedersen et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2013)
Inflammation markers after randomization to abacavir/lamivudine or tenofovir/emtricitabine with efavirenz or atazanavir/ritonavir
Grace A. McComsey et al.
AIDS (2012)
Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatment
Jacqueline Capeau et al.
AIDS (2012)
Immune deficiency could be an early risk factor for altered insulin sensitivity in antiretroviral-naive HIV-1-infected patients: the ANRS COPANA cohort
Faroudy Boufassa et al.
ANTIVIRAL THERAPY (2012)
Relationship between monocyte/macrophage activation marker soluble CD163 and insulin resistance in obese and normal-weight subjects
Markella V. Zanni et al.
CLINICAL ENDOCRINOLOGY (2012)
HIV Status, Burden of Comorbid Disease, and Biomarkers of Inflammation, Altered Coagulation, and Monocyte Activation
Kaku A. Armah et al.
CLINICAL INFECTIOUS DISEASES (2012)
Risk of type 2 diabetes among HIV-infected and healthy subjects in Italy
Laura Galli et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2012)
Metabolic Syndrome Before and After Initiation of Antiretroviral Therapy in Treatment-Naive HIV-Infected Individuals
Supriya Krishnan et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2012)
Microbial translocation in HIV infection: causes, consequences and treatment opportunities
Netanya G. Sandler et al.
NATURE REVIEWS MICROBIOLOGY (2012)
Inflammation, Coagulation and Cardiovascular Disease in HIV-Infected Individuals
Daniel A. Duprez et al.
PLOS ONE (2012)
Risk of Diabetes Mellitus in Persons with and without HIV: A Danish Nationwide Population-Based Cohort Study
Line D. Rasmussen et al.
PLOS ONE (2012)
The prevalence and pathogenesis of diabetes mellitus in treated HIV-infection
Il Joon Paik et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Changes in Inflammatory and Coagulation Biomarkers: A Randomized Comparison of Immediate versus Deferred Antiretroviral Therapy in Patients With HIV Infection
Jason V. Baker et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2011)
Soluble CD163, a Novel Marker of Activated Macrophages, Is Elevated and Associated With Noncalcified Coronary Plaque in HIV-Infected Patients
Tricia H. Burdo et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Plasma Levels of Soluble CD14 Independently Predict Mortality in HIV Infection
Netanya G. Sandler et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Association Between Systemic Inflammation and Incident Diabetes in HIV-Infected Patients After Initiation of Antiretroviral Therapy
Todd T. Brown et al.
DIABETES CARE (2010)
Insulin Sensitivity in Multiple Pathways Is Differently Affected During Zidovudine/Lamivudine-Containing Compared With NRTI-Sparing Combination Antiretroviral Therapy
Marit G. A. van Vonderen et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2010)
Inflammation and Mortality in HIV-Infected Adults: Analysis of the FRAM Study Cohort
Phyllis C. Tien et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2010)
Markers of Inflammation, Coagulation, and Renal Function Are Elevated in Adults with HIV Infection
Jacqueline Neuhaus et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Prevalence and Pathogenesis of Diabetes Mellitus in HIV-1 Infection Treated With Combined Antiretroviral Therapy
Katherine Samaras
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2009)
Serum Immune Activation Markers Are Persistently Increased in Patients with HIV Infection after 6 Years of Antiretroviral Therapy despite Suppression of Viral Replication and Reconstitution of CD4+ T Cells
Martyn A. French et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Incidence and risk factors for new-onset diabetes, in HIV-infected patients -: The data collection on adverse events of Anti-HIV drugs (D:A:D) study
Stephane De Wit et al.
DIABETES CARE (2008)
Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection
Lewis H. Kuller et al.
PLOS MEDICINE (2008)
Effects of ritonavir and amprenavir on insulin sensitivity in healthy volunteers
Grace A. Lee et al.
AIDS (2007)
Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the swiss HIV cohort study
Bruno Ledergerber et al.
CLINICAL INFECTIOUS DISEASES (2007)
Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the Multicenter AIDS Cohort Study
TT Brown et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Prevalence of diabetes mellitus and dyslipidemia among antiretroviral naive patients co-infected with hepatitis C virus (HCV) and HIV-1 compared to patients without co-infection
F Visnegarwala et al.
JOURNAL OF INFECTION (2005)
Effects of HIV disease on lipid, glucose and insulin levels: results from a large antiretroviral-naive cohort
W El-Sadr et al.
HIV MEDICINE (2005)
Impact of HIV infection and HAART on serum lipids in men
SA Riddler et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy
PW Hunt et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Metabolic effects of indinavir in healthy HIV-seronegative men
MA Noor et al.
AIDS (2001)
Share Paper
